Clinical Trial Record

Return to Clinical Trials

Comparison of Metal and Plastic Stents for Preoperative Biliary Decompression


2010-07


2022-10-13


2022-10-13


61

Study Overview

Comparison of Metal and Plastic Stents for Preoperative Biliary Decompression

Covered self expandable metal stents (CSEMS) are three times larger in diameter than 10 Fr plastic stents. When compared to plastic stents, randomized trials have shown longer patency and fewer stent-related complications for CSEMS. The investigators hypothesize that placement of CSEMS would be a better treatment option for preoperative biliary decompression in patients with pancreatic cancer.

Covered self expandable metal stents (CSEMS) are three times larger in diameter than 10 Fr plastic stents. When compared to plastic stents, randomized trials have shown longer patency and fewer stent-related complications for CSEMS. The investigators hypothesize that placement of CSEMS would be a better treatment option for preoperative biliary decompression in patients with pancreatic cancer as there will be better drainage of the obstructed biliary system with fewer adverse events.

  • Obstructive Jaundice
  • Pancreatic Cancer
  • PROCEDURE: Metal stent
  • PROCEDURE: Plastic stent
  • FT356090

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates Results Reporting Dates Study Record Updates

2010-08-12  

N/A  

2023-07-11  

2010-08-30  

N/A  

2023-07-12  

2010-08-31  

N/A  

2023-07  

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

Design Details

Primary Purpose:
Treatment


Allocation:
Randomized


Interventional Model:
Parallel


Masking:
None


Arms and Interventions

Participant Group/ArmIntervention/Treatment
ACTIVE_COMPARATOR: Metal stent

Patients with pancreatic cancer causing bile duct obstruction will be treated by placement of a metal stent.

PROCEDURE: Metal stent

  • Patients with pancreatic cancer causing bile duct obstruction will be treated by placement of a metal stent.
ACTIVE_COMPARATOR: Plastic Stent

Patients with pancreatic cancer causing bile duct obstruction will be treated by placement of a plastic stent

PROCEDURE: Plastic stent

  • Patients with pancreatic cancer causing bile duct obstruction will be treated by placement of a 10Fr plastic stent.
Primary Outcome MeasuresMeasure DescriptionTime Frame
Complications related to stent dysfunctionComplications related to stent dysfunction which include hyperbilirubinemia or cholangitis that warrant stent exchange (repeat intervention by ERCP)30 days
Secondary Outcome MeasuresMeasure DescriptionTime Frame
Procedural complicationsComplications related to the procedure which includes pancreatitis, perforation or hemorrhage.30 days

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person’s general health condition or prior treatments.

Ages Eligible for Study:
ALL

Sexes Eligible for Study:
19 Years

Accepts Healthy Volunteers:

    Inclusion Criteria:

  • Patients with pancreatic cancer and mass in the head of pancreas causing jaundice.
  • Patients 19 yrs of age and older
  • Serum bilirubin > 2mg/dl
  • CT: No evidence of distant metastasis or local vascular invasion (tumor surrounding portal or mesenteric vessels for more than 180 degrees of their circumference or an irregular vessel margin).

  • Exclusion Criteria:

  • Karnofsky score < 60
  • Prior (ERCP or PTC) attempts at biliary decompression for the same indication
  • Tumor-related gastric outlet obstruction (vomiting and oral intake of < 1L/day)
  • Ongoing or planned neoadjuvant therapy
  • Cholangitis at presentation or coagulopathy needing reversal medication
  • Post-surgical anatomy
  • Multiple extra-hepatic biliary strictures or concomitant stricture in liver hilum
  • Failed ERCP's (Definition: Inability to deploy a biliary stent thereby requiring a PTC or surgery).

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

  • University of Virginia

  • PRINCIPAL_INVESTIGATOR: Muhammad Hasan, MD, AdventHealth

Publications

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

General Publications

No publications available